AQP4 and myeloid sarcoma: These findings were replicated in Korean and Chinese populations in whom a distinction of MS from AQP4 ab–positive NMOSD and MOGAD was achievable with good sensitivity and specificity (287, 288); data on a distinction between MOGAD and AQP4 ab–positive NMOSD were not provided.